全文获取类型
收费全文 | 32300篇 |
免费 | 1658篇 |
国内免费 | 99篇 |
专业分类
耳鼻咽喉 | 684篇 |
儿科学 | 1277篇 |
妇产科学 | 515篇 |
基础医学 | 3832篇 |
口腔科学 | 628篇 |
临床医学 | 2173篇 |
内科学 | 8384篇 |
皮肤病学 | 1236篇 |
神经病学 | 2476篇 |
特种医学 | 805篇 |
外科学 | 4628篇 |
综合类 | 122篇 |
一般理论 | 7篇 |
预防医学 | 2590篇 |
眼科学 | 796篇 |
药学 | 1919篇 |
中国医学 | 78篇 |
肿瘤学 | 1907篇 |
出版年
2023年 | 180篇 |
2022年 | 201篇 |
2021年 | 751篇 |
2020年 | 324篇 |
2019年 | 800篇 |
2018年 | 1195篇 |
2017年 | 763篇 |
2016年 | 702篇 |
2015年 | 779篇 |
2014年 | 829篇 |
2013年 | 1276篇 |
2012年 | 2198篇 |
2011年 | 2399篇 |
2010年 | 1282篇 |
2009年 | 991篇 |
2008年 | 1962篇 |
2007年 | 2106篇 |
2006年 | 1926篇 |
2005年 | 1964篇 |
2004年 | 1763篇 |
2003年 | 1720篇 |
2002年 | 1633篇 |
2001年 | 1109篇 |
2000年 | 1372篇 |
1999年 | 1022篇 |
1998年 | 180篇 |
1997年 | 125篇 |
1996年 | 130篇 |
1995年 | 88篇 |
1994年 | 59篇 |
1993年 | 67篇 |
1992年 | 338篇 |
1991年 | 260篇 |
1990年 | 207篇 |
1989年 | 161篇 |
1988年 | 157篇 |
1987年 | 158篇 |
1986年 | 123篇 |
1985年 | 117篇 |
1984年 | 85篇 |
1983年 | 65篇 |
1981年 | 34篇 |
1979年 | 55篇 |
1976年 | 31篇 |
1974年 | 31篇 |
1973年 | 34篇 |
1972年 | 29篇 |
1971年 | 27篇 |
1970年 | 25篇 |
1968年 | 28篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
991.
992.
993.
I. Aiza-Haddad A. Ballesteros-Amozurrutia O.D. Borjas-Almaguer M. Castillo-Barradas G. Castro-Narro N. Chávez-Tapia R.A. Chirino-Sprung L. Cisneros-Garza M. Dehesa-Violante J. Flores-Calderón A. Flores-Gaxiola I. García-Juárez M.S. González-Huezo E.I. González-Moreno F. Higuera-de la Tijera D. Kershenobich-Stalnikowitz E. López-Méndez R. Malé-Velázquez F. Bosques-Padilla 《Revista de gastroenterologia de Mexico》2018,83(3):275-324
The aim of the Mexican Consensus on the Treatment of Hepatitis C was to develop clinical practice guidelines applicable to Mexico. The expert opinion of specialists in the following areas was taken into account: gastroenterology, infectious diseases, and hepatology. A search of the medical literature was carried out on the MEDLINE, EMBASE, and CENTRAL databases through keywords related to hepatitis C treatment. The quality of evidence was subsequently evaluated using the GRADE system and the consensus statements were formulated. The statements were then voted upon, using the modified Delphi system, and reviewed and corrected by a panel of 34 voting participants. Finally, the level of agreement was classified for each statement. The present guidelines provide recommendations with an emphasis on the new direct-acting antivirals, to facilitate their use in clinical practice. Each case must be individualized according to the comorbidities involved and patient management must always be multidisciplinary. 相似文献
994.
Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD programme 下载免费PDF全文
K. Cusi N. Sattar L.‐E. García‐Pérez I. Pavo M. Yu K. E. Robertson C. A. Karanikas A. Haupt 《Diabetic medicine》2018,35(10):1434-1439
995.
Soheila Zeinali Colette A. Bichsel Nina Hobi Manuela Funke Thomas M. Marti Ralph A. Schmid Olivier T. Guenat Thomas Geiser 《Angiogenesis》2018,21(4):861-871
Idiopathic pulmonary fibrosis is characterized by a progressive scarring and stiffening of the peripheral lung tissue that decreases lung function. Over the course of the disease, the lung microvasculature undergoes extensive remodeling. There is increased angiogenesis around fibrotic foci and an absence of microvessels within the foci. To elucidate how the anti-fibrotic drug nintedanib acts on vascular remodeling, we used an in vitro model of perfusable microvessels made with primary endothelial cells and primary lung fibroblasts in a microfluidic chip. The microvasculature model allowed us to study the impact of nintedanib on permeability, vascularized area, and cell–cell interactions. The anti-vasculogenic impact of nintedanib was visible at the minimal concentrations of 10 nM, showing a significant increase in vessel permeability. Furthermore, nintedanib decreased microvessel density, diameter, and influenced fibroblast organization around endothelial microvessels. These results show that nintedanib acts on the endothelial network formation and endothelial–perivascular interactions. Advanced in vitro microvasculature models may thus serve to pinpoint the mechanistic effect of anti-fibrotic drugs on the microvascular remodeling in 3D and refine findings from animal studies. 相似文献
996.
997.
998.
999.
1000.